Cancer Research5d
Acknowledgment to Reviewers
Clin Cancer Res (2025) 31 (1): 217–224. The Clinical Cancer Research editors wish to acknowledge with sincere appreciation the assistance of the following reviewers who have generously contributed ...
Cancer Research5d
Chemotherapy Sparks Tertiary Lymphoid Structures in Metastatic Ovarian Cancer
1Lab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium. 2Lab of Cellular and Molecular Immunology, Brussels Center for Immunology, Vrijie ...
Cancer Research5d
The Hallmarks of Predictive Oncology
4Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. 12Medical Biophysics, University of Toronto, Toronto, Canada. 13Vector Institute for Artificial Intelligence, Toronto, ...
Cancer Research5d
Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
1Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts.
Cancer Research5d
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors
1Mass General Cancer Center, Boston, Massachusetts. 2Harvard Medical School, Boston, Massachusetts. *Corresponding Author: Gregory M. Cote, Mass General Cancer Center ...
Cancer Research5d
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. 2Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 3Clinical and ...